Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 894-896

  Ouweneel, D M ^a   Engstrom, A E ^a   Sjauw, K D ^a   Hirsch, A ^a   Hill, J M ^b   Gockel, B ^c   Tuseth, V ^d   Van Der Schaaf, R J ^e   Henriques, J P S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c University Hospital of Bielefeld   (Germany)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Cardiogenic shock; Impella; Intra aortic balloon pump; Mechanical support; Randomized controlled trial

Indexed keywords

ANTERIOR MYOCARDIAL INFARCTION; CARDIOGENIC SHOCK; CORONARY ARTERY BLOOD FLOW; DEVICE SAFETY; FEASIBILITY STUDY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADULT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; INTERNATIONAL COOPERATION; LEARNING; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SHOCK, CARDIOGENIC; STANDARDS;

ADULT; AGED; FEMALE; HEART-ASSIST DEVICES; HUMANS; INTERNATIONALITY; INTRA-AORTIC BALLOON PUMPING; LEARNING; MALE; MIDDLE AGED; SHOCK, CARDIOGENIC;

EID: 84960153187     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.10.063     Document Type: Article

References (13)

1. R.J. Goldberg, F.A. Spencer, J.M. Gore, D. Lessard, and J. Yarzebski Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective Circulation 119 2009 1211 1219
2. H. Thiele, U. Zeymer, F.J. Neumann, M. Ferenc, H.G. Olbrich, J. Hausleiter, and et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial Lancet 382 2013 1638 1645
3. K.D. Sjauw, A.E. Engstrom, M.M. Vis, R.J. van der Schaaf, J. Baan Jr., K.T. Koch, and et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur. Heart J. 30 2009 459 468
4. S. Windecker, P. Kolh, F. Alfonso, J.P. Collet, J. Cremer, V. Falk, and et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 35 2014 2541 2619
5. D.M. Ouweneel, and J.P. Henriques Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations Heart 98 2012 1246 1254
6. K.D. Sjauw, M. Remmelink, J. Baan Jr., K. Lam, A.E. Engstrom, R.J. van der Schaaf, and et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery J. Am. Coll. Cardiol. 51 2008 1044 1046
7. M. Remmelink, K.D. Sjauw, J.P. Henriques, R.J. de Winter, K.T. Koch, R.J. van der Schaaf, and et al. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics Catheter. Cardiovasc. Interv. 70 2007 532 537
8. A.E. Engstrom, R. Cocchieri, A.H. Driessen, K.D. Sjauw, M.M. Vis, J. Baan, and et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience Crit. Care Med. 39 2011 2072 2079
9. M. Seyfarth, D. Sibbing, I. Bauer, G. Frohlich, L. Bott-Flugel, R. Byrne, and et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction J. Am. Coll. Cardiol. 52 2008 1584 1588
10. J.P. Henriques, D.M. Ouweneel, S.S. Naidu, I.F. Palacios, J. Popma, E.M. Ohman, and et al. Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study Am. Heart J. 167 2014 472 479 e5
11. F. Burzotta, C. Trani, S.N. Doshi, J. Townend, R.J. van Geuns, P. Hunziker, and et al. Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group Int. J. Cardiol. 201 2015 684 691
12. N.K. Kapur, X. Qiao, V. Paruchuri, and et al. Mechanical preconditioning with acute circulatory support before reperfusion limits infarct size in acute myocardial infarction JACC Heart Fail. 201 2015 684 691
13. W.W. O'Neill, T. Schreiber, D.H. Wohns, C. Rihal, S.S. Naidu, A.B. Civitello, and et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry J. Interv. Cardiol. 27 2014 1 11